Replies to post #84628 on CV Sciences Inc (CVSI)

[Wolf-man jack]

WQLF SAYS: HAVE MERCY WQLF ahoooooo

Ai Generated


CV Sciences (CVSI) stock has shown positive momentum due to improved financial efficiency, including high gross margins ( in Q3 2025) and a strategic focus on cost reduction, aiming for profitability in 2026. Key drivers include the acquisition of Elevated Soft Gels for manufacturing, strong performance of new products (39% of Q3 2025 revenue), and a leading position in the natural product retail channel.

Key Reasons for CVSI Stock Movement:
Improved Profitability & Margins: The company has reported strong gross margins (approx.
- in 2025), driven by cost-saving initiatives and the acquisition of Elevated Soft Gels, which helps with insourcing production.

Strategic Growth & Innovation: New product launches, particularly in the non-cannabinoid space under the Plus Health brand, are contributing significantly to revenue, with products launched since 2023 representing 39% of Q3 2025 sales

Market Position: CVSI maintains a top position in the natural product retail channel.

Cost Management: The company is focusing on reducing operating expenses to reach positive cash flow, aiming for 2026 as a pivotal year for profitability.

Short-Term Momentum: Technical indicators as of early 2026 suggest a potential, albeit volatile, upward trend with support from moving averages.

Risks to Consider

Regulatory Uncertainty: The CBD market faces challenging federal regulations, which can impact sales.
Shrinking Revenue: Despite better margins, the company has faced year-over-year revenue declines in 2025 due to market competition and supply issues.

Volatile Performance: The stock has experienced significant, sometimes erratic, price swings.

Wolfman Jack Said ; What's Up ? CVSI YQU Understand

Have Mercy on Me ahoooooo

[Wolf-man jack]

WQLF SAYS: HAVE MERCY WQLF ahoooooo

Ai Generated


CV Sciences (CVSI) stock has shown positive momentum due to improved financial efficiency, including high gross margins ( in Q3 2025) and a strategic focus on cost reduction, aiming for profitability in 2026. Key drivers include the acquisition of Elevated Soft Gels for manufacturing, strong performance of new products (39% of Q3 2025 revenue), and a leading position in the natural product retail channel.

Key Reasons for CVSI Stock Movement:
Improved Profitability & Margins: The company has reported strong gross margins (approx.
- in 2025), driven by cost-saving initiatives and the acquisition of Elevated Soft Gels, which helps with insourcing production.

Strategic Growth & Innovation: New product launches, particularly in the non-cannabinoid space under the Plus Health brand, are contributing significantly to revenue, with products launched since 2023 representing 39% of Q3 2025 sales

Market Position: CVSI maintains a top position in the natural product retail channel.

Cost Management: The company is focusing on reducing operating expenses to reach positive cash flow, aiming for 2026 as a pivotal year for profitability.

Short-Term Momentum: Technical indicators as of early 2026 suggest a potential, albeit volatile, upward trend with support from moving averages.

Risks to Consider

Regulatory Uncertainty: The CBD market faces challenging federal regulations, which can impact sales.
Shrinking Revenue: Despite better margins, the company has faced year-over-year revenue declines in 2025 due to market competition and supply issues.

Volatile Performance: The stock has experienced significant, sometimes erratic, price swings.

Wolfman Jack Said ; What's Up ? CVSI YQU Understand

Have Mercy on Me ahoooooo

[Wolf-man jack]

WQLF SAYS: HAVE MERCY WQLF ahoooooo

Ai Generated


CV Sciences (CVSI) stock has shown positive momentum due to improved financial efficiency, including high gross margins ( in Q3 2025) and a strategic focus on cost reduction, aiming for profitability in 2026. Key drivers include the acquisition of Elevated Soft Gels for manufacturing, strong performance of new products (39% of Q3 2025 revenue), and a leading position in the natural product retail channel.

Key Reasons for CVSI Stock Movement:
Improved Profitability & Margins: The company has reported strong gross margins (approx.
- in 2025), driven by cost-saving initiatives and the acquisition of Elevated Soft Gels, which helps with insourcing production.

Strategic Growth & Innovation: New product launches, particularly in the non-cannabinoid space under the Plus Health brand, are contributing significantly to revenue, with products launched since 2023 representing 39% of Q3 2025 sales

Market Position: CVSI maintains a top position in the natural product retail channel.

Cost Management: The company is focusing on reducing operating expenses to reach positive cash flow, aiming for 2026 as a pivotal year for profitability.

Short-Term Momentum: Technical indicators as of early 2026 suggest a potential, albeit volatile, upward trend with support from moving averages.

Risks to Consider

Regulatory Uncertainty: The CBD market faces challenging federal regulations, which can impact sales.
Shrinking Revenue: Despite better margins, the company has faced year-over-year revenue declines in 2025 due to market competition and supply issues.

Volatile Performance: The stock has experienced significant, sometimes erratic, price swings.

Wolfman Jack Said ; What's Up ? CVSI YQU Understand

Have Mercy on Me Wolf ahoooooo